T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy
ACS Pharmacology & Translational Science · 10.04.2026 · 9 (4) · 1010-1020
DOI: 10.1021/acsptsci.6c00065 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 28.03.2026. Verfasst von Wenlong Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212001, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiangsu Provincial Department of Education, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212001, China.
ORCID-Profile: Shengxiang Fu, Hsiang-I Tsai
Förderung
- Jiangsu Provincial Department of Education
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Science and Technology Bureau of Zhenjiang
- Jinshan talents in the medical field of Zhenjiang
- Basic Research Program of Zhenjiang City
- Jiangsu Health Commission
Zitieren
APA
Chen, W., Zhang, Z., Zhao, C., Wang, B., Liao, X., Li, Q., Wang, D., Fu, S., & Tsai, H. I. (2026). T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy. ACS Pharmacology & Translational Science, 9(4), 1010-1020. https://doi.org/10.1021/acsptsci.6c00065
Vancouver
Chen W, Zhang Z, Zhao C, Wang B, Liao X, Li Q, et al. T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy. ACS Pharmacology & Translational Science. 2026;9(4):1010-1020. doi:10.1021/acsptsci.6c00065
BibTeX
@article{Chen2026,
author = {Chen, Wenlong and Zhang, Zining and Zhao, Chuangchuang and Wang, Bo and Liao, Xiang and Li, Qinghua and Wang, Dongqing and Fu, Shengxiang and Tsai, Hsiang-I},
title = {T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy},
journal = {ACS Pharmacology & Translational Science},
year = {2026},
volume = {9},
number = {4},
pages = {1010--1020},
doi = {10.1021/acsptsci.6c00065}
}
EUVIMED